Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Assets Average (2016 - 2025)

Historic Assets Average for Ekso Bionics Holdings (EKSO) over the last 13 years, with Q3 2025 value amounting to $22.4 million.

  • Ekso Bionics Holdings' Assets Average fell 2022.49% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year decrease of 2022.49%. This contributed to the annual value of $27.8 million for FY2024, which is 2041.08% down from last year.
  • Latest data reveals that Ekso Bionics Holdings reported Assets Average of $22.4 million as of Q3 2025, which was down 2022.49% from $25.2 million recorded in Q2 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Assets Average peaked at $54.7 million during Q2 2021, and registered a low of $22.4 million during Q3 2025.
  • Its 5-year average for Assets Average is $36.3 million, with a median of $35.5 million in 2023.
  • As far as peak fluctuations go, Ekso Bionics Holdings' Assets Average soared by 17861.71% in 2021, and later plummeted by 2580.79% in 2024.
  • Ekso Bionics Holdings' Assets Average (Quarter) stood at $49.9 million in 2021, then decreased by 19.7% to $40.1 million in 2022, then dropped by 25.07% to $30.1 million in 2023, then decreased by 7.05% to $27.9 million in 2024, then decreased by 19.75% to $22.4 million in 2025.
  • Its Assets Average stands at $22.4 million for Q3 2025, versus $25.2 million for Q2 2025 and $27.0 million for Q1 2025.